Month: September 2024

Miami, FL, Sept. 05, 2024 (GLOBE NEWSWIRE) — Tecnoglass, Inc. (NYSE: TGLS) (“Tecnoglass” or the “Company”), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced that its Board of Directors has declared a quarterly dividend of $0.11 per share, or $0.44 per share on an annualized basis, for the third quarter of 2024. Shareholders of record as of the close of business on September 30, 2024 will be paid a dividend on October 31, 2024. About Tecnoglass Tecnoglass Inc. is a leading producer of high-end aluminum and vinyl windows and architectural glass serving the multi-family, single-family, and commercial end markets. Tecnoglass is the second largest glass fabricator serving the U.S. and the #1 architectural glass...

PLANO, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) — Katapult Holdings, Inc. (“Katapult” or the “Company”) (NASDAQ: KPLT), an e-commerce focused financial technology company, announced that Orlando Zayas, CEO, and Nancy Walsh, CFO, will participate in the H.C. Wainwright 26th Annual Global Investment Conference, which is being held September 9 to 11, 2024. Orlando Zayas will deliver a presentation that will discuss an overview of the Katapult business. The presentation will be available virtually, on-demand beginning at 7:00 AM ET on September 9, 2024. The on-demand audio webcast of the event will be available on the Company’s Investor Relations website (https://ir.katapultholdings.com/). If you are an institutional investor, and would like to listen to the Company’s presentation through the conference website, please click on the following...

BOSTON and SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders, today announced presentations at two upcoming medical conferences: the International League Against Epilepsy (ILAE) 15th Annual European Epilepsy Congress (EEC) in Rome, Italy, September 7-11, 2024, and the 2024 Epilepsy Foundation Pipeline Conference in Atlanta, Ga., September 25-26, 2024. At EEC, Rapport will present on the novel design of a Phase 2a proof-of-concept trial for the company’s lead product candidate RAP-219, which is being studied in patients with drug-resistant focal epilepsy. At the Epilepsy Foundation Pipeline Conference, Rapport...

CAMBRIDGE, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the company is scheduled to present at the 2024 Cantor Global Healthcare Conference on Wednesday, September 18, 2024, at 10:20 a.m. ET. A live webcast of the presentation can be accessed under “Events & Presentations” in the Investors section of the company’s website at www.agios.com. A replay of the webcast will be archived on the company’s website for at least two weeks following the presentation. About AgiosAgios is the pioneering leader in PK activation and is dedicated to developing and delivering transformative therapies for patients living with rare diseases. In the U.S., Agios markets a first-in-class...

Forward+ and Chapter Visualization Leverage Auddia’s Advanced AI Technology to Introduce Leading Podcast Listening Experience Technology Now Available on iOS With Android Targeted for Q4 Features are First Clearly Differentiated Offerings for Podcast Listening on faidr BOULDER, CO, Sept. 05, 2024 (GLOBE NEWSWIRE) — Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) (“Auddia” or the “Company”), a proprietary AI platform for audio identification and classification and related technologies, reinventing how consumers engage with AM/FM radio, podcasts, and other audio content, today announced it recently launched two new differentiated features for podcast listening on the iOS faidr mobile application, Forward+ and Chapter Visualization. Both features are built on the Company’s proprietary audio classification AI and Natural Language Processing...

Justin Kubeck, M.D. of Ocean Pain and Spine in Toms River, NJ Will Lead a Statewide Network of Providers That Use Nociscan to Better Serve This Important Segment of Low Back Pain Population Average Settlement in New Jersey for Personal Injury Claims Involving the Neck and Back is $918,967 Work-related Accidents Which Cause Neck and Back Injuries Have a National Average Settlement of $148,750 BROOMFIELD, CO, Sept. 05, 2024 (GLOBE NEWSWIRE) — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today the launch of a program to develop a statewide network of providers in New Jersey to utilize Nociscan throughout the personal...